|
|
|
|
Anti-RTN1 / Reticulon 1 Antibody (C-Terminus) LS-C102340
Most Popular RTN1 / Reticulon 1 Antibodies
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|
|
||||||||
|
Details
| Human RTN1 / Reticulon 1 | |
| Rabbit | |
| Human, Monkey, Mouse, Rat, Dog, Guinea pig, Horse, Pig, Rabbit, Zebrafish (tested or 100% immunogen sequence identity) | |
| Bovine, Chicken (at least 90% immunogen sequence identity) | |
| IgG Polyclonal | |
| Unconjugated. Also available conjugated with Biotin, FITC, HRP. | |
| Immunoaffinity purified | |
| Unmodified |
Applications
- Western blot (0.2 - 1 µg/ml)
- (applications tested for the base form of this product only)
Specificity and Use
| Synthetic peptide from C-Terminus of human RTN1 (Q9BQ59, NP_996734). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Marmoset, Mouse, Rat, Elephant, Dog, Rabbit, Horse, Pig, Guinea pig, Sablefish, Stickleback, Pufferfish, Zebrafish (100%); Gibbon, Bovine, Turkey, Zebra finch, Chicken, Platypus (92%); Medaka (90%); Orangutan, Galago, Sheep, Bat, Opossum, Lizard, Catfish (85%). | ||
|
||
| C-Terminus | ||
| Human RTN1 / Reticulon 1 | ||
| Western Blot: Suggested dilution at 1µg/ml in 5% skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:1562500. |
Packaging
| Lyophilized from PBS with 2% sucrose | |
| Distilled water | |
| Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year); Short term (less than one week): +4°C. Avoid repeat freeze-thaw cycles. | |
| For research use only. |
About RTN1 / Reticulon 1
Q16799
NM_021136
NP_066959.1
RTN1 Antibody, Reticulon-1 Antibody, NSP Antibody, Reticulon 1 Antibody
RTN1 / Reticulon 1 belongs to the family of reticulon encoding genes. Reticulons are associated with the endoplasmic reticulum, and are involved in neuroendocrine secretion or in membrane trafficking in neuroendocrine cells. This gene is considered to be a specific marker for neurological diseases and cancer, and is a potential molecular target for therapy. Alternative splicing results in multiple transcript variants.
Print This Page
Technical Help
Review This Product
|
Requested From:
Date Requested: 8/18/2017
Date Requested: 8/18/2017
